-
CycleTrack and SDN are teaming up to make medical school admissions more transparent and accessible! Read the announcement to learn how we’re supporting the future of CycleTrack’s free application-tracking tools .
- Home
- Forums
- Physician and Resident Communities (MD / DO)
- Internal Medicine and IM Subspecialties
- Cardiology
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
afterload reduction in acute CHF
Started by obiwan
Get help with your application
Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.
afterload reduction is very important to treat in acute chf exacerbation. afterload is essentially the force that the heart has work against to overcome systemic pressures; the more work, the more stress on the heart. we typically use ace-inhibitors/arbs and nitrates. hydralazine can be a nasty long-term drug and we typically use it if someone has a contraindication to ace/arb and/or have class III-IV heart failure who are already maxed on their heart failure regimen.
also inotropes (dobutamine/milrinone) cause vasodilation which reduces afterload.
also inotropes (dobutamine/milrinone) cause vasodilation which reduces afterload.
Advertisement - Members don't see this ad
BP control is definitely important but lowering BP beyond ~125/80 in name of reducing afterload in counterproductive in IMO. If you want to lower afterload, one of the best drug is minoxidil. But those vasodilations cause tachycardia leading to increased mortality forcing FDA to slap a black box warning that you need diuretic and beta blocker on abroad. But in acute CHF increasing beta blocker dose is absolutely the wrong way to go about it.
I am not a big fan of hydralazine. Weak antihypertensive even if you use TID dose. I do use hydralazine and ISDN together if contraindication to Acei/arb or if the patient is black and has very bad CHF.
But again I am not a heart failure/cardiology fellow; so, I'll defer to the experts.
I am not a big fan of hydralazine. Weak antihypertensive even if you use TID dose. I do use hydralazine and ISDN together if contraindication to Acei/arb or if the patient is black and has very bad CHF.
But again I am not a heart failure/cardiology fellow; so, I'll defer to the experts.
Swan ganz and nitroprusside
IV vasodilators are the best treatment in theory for ADHF provided they can be tolerated.
There are 3 problems you can aim to fix: (1)high preload, (2)poor output and (3)high SVR.
Diuretics address the preload problem(1).
Inotropes address the output and therefore the preload(1,2).
Vasodilators address the high SVR which increases CO and decreases preload (1,2,3).
Like the poster above said, nitroprusside is the way to go. Swan maybe helpful but only in the right hands.
In practice most people get diuresed to dry weight and shown the door, with escalation to inotropes if things start to go south (GFR, BP etc). In other words, the reverse of theory based on familiarity and ease of use. In my experience at least.
There are 3 problems you can aim to fix: (1)high preload, (2)poor output and (3)high SVR.
Diuretics address the preload problem(1).
Inotropes address the output and therefore the preload(1,2).
Vasodilators address the high SVR which increases CO and decreases preload (1,2,3).
Like the poster above said, nitroprusside is the way to go. Swan maybe helpful but only in the right hands.
In practice most people get diuresed to dry weight and shown the door, with escalation to inotropes if things start to go south (GFR, BP etc). In other words, the reverse of theory based on familiarity and ease of use. In my experience at least.